文献速递主动脉疾病

Triveneto Conformable登记研究中Conformable腔内移植物治疗严重瘤颈成角的早期结果

Early outcomes of the Conformable endograft in severe neck angulation from the Triveneto Conformable Registry.
PubMed 文献 · J Vasc Surg · 2023-06-16

该研究回顾性分析意大利Triveneto地区9个血管外科中心2019年1月至2022年7月前瞻性入组、使用Excluder Conformable主动控制系统(CEXC)治疗腹主动脉瘤的患者,聚焦肾下成角≥60°的严重瘤颈成角(SNA)亚组56例。结果显示技术成功率100%,围手术期重大并发症率1.7%,24个月免于再干预率92%,作者认为早期结果良好,但需更长随访和更大队列确认。

要点

  • SNA组56例(占129例的43%),中位随访13个月,技术成功率100%,围手术期重大并发症率1.7%。
  • 围手术期无I型内漏,再干预2例(3.5%),24个月免于再干预率92%。
  • 瘤囊缩小15例(26%)、稳定35例(62%),术后肾下成角中位75°。

核心结论

  • Triveneto Conformable登记研究显示CEXC装置在严重成角肾下瘤颈中早期结果良好,但数据需更长随访和更广泛患者队列确认,以进一步提高SNA患者腔内修复的适用性。

研究设计与样本

  • 多中心回顾性分析,前瞻性入组意大利Triveneto地区(意大利东北部)9个血管外科中心2019年1月至2022年7月使用CEXC装置治疗腹主动脉瘤的患者。
  • 共入组129例,其中肾下成角≥60°的SNA组56例(43%)纳入分析,平均年龄78.9±5.9岁,腹主动脉瘤直径中位59 mm(范围45-94 mm)。

主要发现

  • SNA组肾下瘤颈长度中位22 mm(范围13-58 mm)、成角中位77°(范围60°-150°)、直径22.0±3.5 mm。
  • 技术成功率100%,围手术期重大并发症率1.7%,术中及围手术期并发症率3.5%(臀部跛行1例、腹股沟手术切开1例),围手术期死亡率0%,围手术期无I型内漏。
  • 中位随访13个月(范围1-40个月),随访期间5例死于动脉瘤无关原因,再干预2例(3.5%)(1例因IA型内漏转为开放手术,1例因II型内漏行瘤囊栓塞)。
  • 瘤囊缩小15例(26%)、瘤囊稳定35例(62%),24个月免于再干预率估计为92%,术后主动脉瘤颈成角中位75°(范围45°-139°)。

局限性

  • 原文结论指出这些数据需更长随访和更广泛患者队列确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The study reports retrospective evaluation of early outcomes from a multicentric experience with the Excluder conformable endograft with active control system (CEXC Device) in the treatment of abdominal aortic aneurysms. Its design allows more flexibility, given by proximal unconnected stent rows and a bending wire within the delivery catheter enables control of proximal angulation. This study specifically focuses on the severe neck angulation (SNA) subgroup (≥60°). METHODS: All patients treated with CEXC Device in nine vascular surgery centers of Triveneto area (Northeast Italy) between January 2019 and July 2022 were enrolled prospectively and analyzed retrospectively. Demographic and aortic anatomical characteristics were evaluated. Endovascular aneurysm repair in SNA were selected for analysis. Major investigated outcomes were technical success, endoleaks, morbidity, mortality, and reinterventions at 30 days and during follow-up. Endograft migration and postoperative aortic neck angulation changes were also analyzed. RESULTS: A total of 129 patients were enrolled. An infrarenal angle of ≥60° was observed in 56 patients (43%) (SNA group) and their data analyzed. The mean patient age was 78.9 ± 5.9 years and median abdominal aortic aneurysm diameter 59 mm (range, 45-94 mm). Median aortic infrarenal neck length, angulation and diameter were 22 mm (range, 13-58 mm), 77° (range, 60°-150°), and 22.0 ± 3.5 mm respectively. Analysis revealed a technical success rate of 100% and perioperative major complication rate of 1.7%. Intraoperative and perioperative morbidity and mortality rates were 3.5% (one buttock claudication and one inguinal surgical cutdown) and 0%, respectively. No perioperative type I endoleaks were observed. The median follow-up was 13 months (range, 1-40 months). Five patients died during follow-up from aneurysm-unrelated causes. Two reinterventions occurred (3.5%): one conversion for a type IA endoleak and one sac embolization for a type II endoleak. Aneurysm sac shrinkage was observed in 15 patients (26%) and aneurysm stability in 35 patients (62%), respectively. Estimated freedom from reinterventions at 24 months was 92%. Aortic neck median postoperative angulation was 75° (range, 45°-139°). CONCLUSIONS: The Triveneto Conformable Registry shows good early results of the CEXC device in severely angulated aortic infrarenal necks. These data need confirmation on longer follow-up and a wider cohort of patients to further increase endovascular aneurysm repair eligibility in SNA.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Bonvini S, Spadoni N, Frigatti P, et al. Early outcomes of the Conformable endograft in severe neck angulation from the Triveneto Conformable Registry. J Vasc Surg. 2023. PMID: 37330149. doi:10.1016/j.jvs.2023.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。